genedrive plc is focused on decentralising molecular diagnostics, concentrating on applications where our technology will provide sustainable growth
Diagnostics: Rapid and accurate diagnosis of infectious disease facilitating immediate therapeutic treatment.
Pharmacogenomics: Allowing medicine to be personalised around an individual patient's genotype.
Future applications: Genedrive® is being validated for use in the areas of pathogen detection & biosurveillance and aquaculture.
genedrive plc at a glance >
Share price details >
View all regulatory news >
27 November 2020
Annual Report and Accounts 2020
View all reports >
Friday November 20, 2020
FTSE 100 ends the week higher, Wall Street mixed on vaccine hopes, Fed fears
The Parkmead Group rises after upbeat results statement
Proactive news headlines: Block Energy, ImmuPharma, Genedrive, Argentex Group …
View all news >
On the 8th June 2018 Genedrive Plc disposed of the business and assets of Epistem Ltd. Please follow this link to be redirected to the website of Epistem Ltd
© 2017-20 genedrive plc
Don't show this again